RAS at the Golgi antagonizes malignant transformation through PTPRκ-mediated inhibition of ERK activation.
Casar B, Badrock AP, Jiménez I, Arozarena I, Colón-Bolea P, Lorenzo-Martín LF, Barinaga-Rementería I, Barriuso J, Cappitelli V, Donoghue DJ, et al. Nat Commun. 2018 Sep 5; 9(1):3595. Epub 2018 Sep 5.